Rhon-klinikum Ag · XETR:RHK

Rhon-klinikum — H1 2017 Earnings Presentation

10 slides from Rhon-klinikum's earnings presentation, Aug 3, 2017

  1. Slide 1: First Half-Year Results 2017

    First Half-Year Results 2017 3 August 2017 Stephan Holzinger, CEO Dr. Kai G. Klinger RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1

  2. Slide 2: Disclaimer

    Disclaimer  This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose

  3. Slide 3: Highlights of Second Quarter 2017

    Highlights of Second Quarter 2017  Weaker volume growth  Inpatient and outpatient cases grew by +2.1% to 422,950 cases  Decrease in DRG case mix points in Q2 cancels out growth in Q1 (main reasons: DRG catalogue effect, MDK corrections, shift in demand)  UKGM separate accounting  Groundbreaking

  4. Slide 4: Key P&L Figures First Half Year 2017

    Key P&L Figures First Half Year 2017 Performance* vs. Half-year results reflect an ambitious corporate H1 2017 in € millions H1 2016 environment Revenue 598.4 100.0% 1.3%  Revenue growth burdened by weaker volumes and challenging 2017 Personnel exp. -391.5 65.4% 3.8% reimbursement scheme Cost of ma

  5. Slide 5: UKGM Performance and Separate Accounting

    UKGM Performance and Separate Accounting  UKGM with positive revenue development H1 2017  Revenues +2.8% (yoy)  EBITDA margin 6.3%  Breakthrough solution with State of Hesse in separate accounting  UKGM receives additional €15m p.a. from 2017 onwards  Contractual consideration of future wage a

  6. Slide 6: Core Balance Sheet Figures as of June 2017

    Core Balance Sheet Figures as of 30 June 2017 €1,452m €1,452m 62 % €906m Non-current assets €1,107m 76 % Equity €5m cash €547m 38 % Current assets € 25m Non-current liabilities 2% €10m financial debt €320m Current liabilities 22 % €261m cash Assets Equity & Liabilities  Gradually decreasing net cas

  7. Slide 7: Improvement Program & Financial Outlook

    Improvement Program & Financial Outlook Rollout of comprehensive improvement programme with high priority package of measures  Stem MDK reviews and corrections  Effectiveness and benchmarking of staff allocation  Capacity utilisation and medical offer for each location in terms of earnings contri

  8. Slide 8: Appendix Financial Calendar

    Appendix Financial Calendar FY 2017  24 February 2017 Preliminary results for financial year 2016  7 April 2017 Press conference: publication of annual financial report 2016  5 May 2017 Publication of interim report for the quarter ending 31 March 2017  7 June 2017 Annual General Meeting (Jahrhu

  9. Slide 9: Price Regulation in 2017 at a Glance

    Appendix Price Regulation in 2017 at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level  Wage sum increase as main reference number for 1 RHÖN effective base rate Benchmark (wage sum) DRG inflation in 2017: +2.5%

  10. Slide 10: Appendix Shareholder Base

    Appendix Shareholder Base Shareholder Structure as of 30 June 2017, according to the most recent notifications of voting rights at that time 25.1% Asklepios 29.8% 1) 33.0% Free Float 67.0% Strategic 3.2% Investors Landeskrankenhilfe 25.0% 3) 5.4% B. Braun Ingeborg Münch 11.5% 2) Eugen Münch/HCM SE 1

Rhön-Klinikum — H1 2017 Earnings Presentation on 6ix